In addition, the inhibition of anaplerosis, the metabolic reactions that generate TCA cycle intermediates, by knockdown of phosphoenolpyruvate carboxykinase 1 (PCK1) also showed protection against hepatic oxidative stress, inflammation, and insulin resistance [53]. The gene discussed is PCK1; the disease is Insulin resistance.